$Invivyd(IVVD)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-25-277894 Act: 34 Size: 17 KB 网页链接
Invivyd(IVVD)
2025-11-15 01:05
$Invivyd(IVVD)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001274173-25-000285 Act: 34 Size: 10 KB 网页链接
Invivyd(IVVD)
01-31 05:15
$Invivyd(IVVD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-031819 Size: 5 KB 网页链接
Invivyd(IVVD)
2025-11-21 05:25
$Invivyd(IVVD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-289825 Size: 4 KB 网页链接
Invivyd(IVVD)
2025-12-23 20:15
$Invivyd(IVVD)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-329488 Act: 34 Size: 319 KB 网页链接
SeekingBiotech新药
2025-12-27 22:38
$Invivyd(IVVD)$ IVVD announced that the FDA has granted Fast Track designation for VYD2311, an investigational vaccine-alternative monoclonal antibody candidate for the prevention of COVID . 快速通道资格认定。比孤儿药这种没用的好多了。